Quest Diagnostics Sets New 1-Year High at $64.38 (DGX)
Shares of Quest Diagnostics (NYSE:DGX) reached a new 52-week high on Wednesday , American Banking and Market News reports. The company traded as high as $64.38 and last traded at $64.09, with a volume of 806,823 shares changing hands. The stock had previously closed at $63.09.
A number of research firms have recently commented on DGX. Analysts at Goldman Sachs upgraded shares of Quest Diagnostics from a “buy” rating to a “conviction-buy” rating in a research note on Wednesday. They now have a $78.00 price target on the stock, up previously from $66.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Quest Diagnostics in a research note on Friday, August 1st. They now have a $64.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Quest Diagnostics in a research note on Friday, July 25th. They now have a $65.00 price target on the stock, up previously from $60.00. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. Quest Diagnostics currently has an average rating of “Hold” and an average target price of $62.46.
The stock’s 50-day moving average is $61.56 and its 200-day moving average is $58.43. The company has a market cap of $9.221 billion and a P/E ratio of 11.85.
Quest Diagnostics (NYSE:DGX) last announced its earnings results on Thursday, July 24th. The company reported $1.08 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.06 by $0.02. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.88 billion. During the same quarter last year, the company posted $1.06 earnings per share. Quest Diagnostics’s revenue was up 4.8% compared to the same quarter last year. On average, analysts predict that Quest Diagnostics will post $4.05 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 22nd. Shareholders of record on Tuesday, October 7th will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.09%. The ex-dividend date is Friday, October 3rd.
Quest Diagnostics Incorporated (NYSE:DGX) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.
Receive News & Ratings for Quest Diagnostics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.